Literature DB >> 25317035

Chemoport-skin erosion: our experience.

K Harish1.   

Abstract

Chemoports are totally implantable venous access devices, which are retained over long periods of time to facilitate chemotherapy administration. Skin erosion is a rare complication wherein there is breach in the skin overlying the septum. This study reports the author's experience of skin erosion in three cases. Ports were explanted in all cases. Skin incision for port placement should be placed away from the access site and repeated access at the same point must be avoided to lessen the incidence of skin erosions.

Keywords:  chemoport; skin erosion; totally implantable venous device

Year:  2014        PMID: 25317035      PMCID: PMC4169101          DOI: 10.1055/s-0033-1353734

Source DB:  PubMed          Journal:  Int J Angiol        ISSN: 1061-1711


  4 in total

1.  Subcutaneous implantable venous access device erosion through the skin in patients treated with anti-vascular endothelial growth factor therapy: a case series.

Authors:  Khaldoun Almhanna; Robert J Pelley; G Thomas Budd; Jon Davidson; Halle C F Moore
Journal:  Anticancer Drugs       Date:  2008-02       Impact factor: 2.248

Review 2.  Complications associated with the use of central venous access devices.

Authors:  E D Whitman
Journal:  Curr Probl Surg       Date:  1996-04       Impact factor: 1.909

3.  Fifty-five patient years' experience with a totally implanted system for intravenous chemotherapy.

Authors:  H Brincker; G Saeter
Journal:  Cancer       Date:  1986-03-15       Impact factor: 6.860

4.  Experience with subcutaneous infusion ports in three hundred patients.

Authors:  T E Brothers; L K Von Moll; J E Niederhuber; J A Roberts; S Walker-Andrews; W D Ensminger
Journal:  Surg Gynecol Obstet       Date:  1988-04
  4 in total
  1 in total

1.  Implantable Port Devices, Complications and outcome in Pediatric Cancer, a Retrospective Study.

Authors:  H Esfahani; M Ghorbanpor; A Tanasan
Journal:  Iran J Ped Hematol Oncol       Date:  2016-03-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.